P PRIMESTOCKFINDER.COM

REC Shares Recharge Metals Limited

ASX · ASX
$0.04 +2.78% Prices as of close 2026-10-27

Last in our picks 2026-10-23 — not in the current list; analysis below is from that screen

Antimicrobial pipeline progress and strong momentum offer catalyst-driven upside.

  • ▸Strong 90-day momentum and clinical catalysts.
  • ▸Above 50-day MA (+20.36%)
  • ▸Above 200-day MA — long-term uptrend

Trend: REC is trading above the 50-day average (+23.33%), RSI 59 — neutral momentum, with a 3-month return of +117.65%.

Valuation & quality: Recharge Metals Limited trades on price-to-book 1.61; fundamentals show net margin 0.0%, return on equity -21.0%, revenue growth 39.5% year on year.

Our screen: BUY (score 3) — Antimicrobial pipeline progress and strong momentum offer catalyst-driven upside.

Computed from end-of-day data; not personal advice.

0.04 0.01 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-08 → 2026-10-27 (AUD). Range 0.01 – 0.04.
Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
+0.00%+0.00%-33.30%+0.00%+0.00%+0.00%+50.00%+33.30%
Market cap
$45.7M
EPS (ttm)
$-0.01
Price / book
1.61
Beta
0.53
Net margin
0.0%
ROE
-21.0%
Revenue growth
39.5%
Revenue (ttm)
$21,679
Free cash flow
$261,886
Debt / equity
0%
52-wk range
$0.01 – $0.05
Volume
237,462
Avg volume (3m)
1,603,898
RSI (14)
59.3
vs 50-day MA
+23.33%
1-mo return
+2.78%
3-mo return
+117.65%
Volume z-score
-0.07

Recharge Metals Limited focuses on the acquisition, exploration, and development of mineral properties in Australia, Canada, and the United States. The company explores for lithium, copper, gold, and uranium deposits. Recharge Metals Limited was incorporated in 2021 and is based in Perth, Australia.

Sector: Basic Materials · Industry: Other Industrial Metals & Mining · Australia · Website

Browse: all ASX stocks · Biotech picks · today's movers

General information only (Australia). This is general information, not financial product advice. It doesn't consider your objectives, financial situation or needs — consider its appropriateness and seek licensed advice before acting. Not a recommendation to buy or sell any financial product.

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.